Use of clomipramine in treatment of obsessive‐compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study
The DOI matches its Crossref record.
Abstract
Objective To evaluate the efficacy and tolerance of a treatment protocol for obsessive‐compulsive disorder, separation anxiety and noise phobia in dogs. Design A study was undertaken to assess clinical responses in 24 dogs diagnosed with one or more of three behavioural disorders stated above to a treatment regimen that included clomipramine and behaviour modification. Procedure A detailed behavioural and clinical history was obtained for each dog. Obsessive‐compulsive disorder was diagnosed in nine cases: primary presenting complaints were tail‐chasing, shadow‐chasing, circling and chewing; one case was diagnosed with concurrent separation anxiety. Separation anxiety was diagnosed in 14 cases: presenting complaints included destruction, vocalisation and escaping in the absence of the owner; four cases also exhibited noise phobia. The study also included one dog diagnosed with noise phobia only and another with inappropriate fear responses. Clomipramine was administered orally twice daily. The starting dose was 1 to 2 mg/kg bodyweight. The dose was increased incrementally to a maximum of 4 mg/kg if needed. A behaviour modification program was designed and the owner instructed on its implementation. Dogs continued medication for at least 1 month after clinical signs disappeared or were acceptably reduced, then withdrawal of medication was attempted by decreasing drug dosage at weekly intervals while behaviour modification continued. Results The presenting clinical sign was largely improved or disappeared in 16 dogs, 5 demonstrated slight to moderate improvement and the behaviour was unchanged in 3. Clomipramine withdrawal was attempted in nine cases: this was successful in five. Conclusion Clomipramine was effective and well‐tolerated in controlling signs of obsessive‐compulsive disorder and/or separation anxiety and/or noise phobia in 16 of 24 assessable cases, when used in combination with behaviour modification, and improvement in clinical signs was noted in 5 others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
“The efficacy of serotonin reuptake inhibitors in these conditions lends support to the phenomenological resemblance of such canine disorders to OCD (Wynchank & Berk, 1998; Seksel & Lindeman, 2001).”
BackgroundLeigh, H. (2015) · Handbook of Consultation-Liaison Psychiatry · doi:10.1007/978-3-319-11005-9_14 · Cited by 309
The use of imepitoin (Pexion™) on fear and anxiety related problems in dogs – a case series
McPeake, K. J., & Mills, D. S. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1098-0 · Cited by 41
Differential gene expression in brain tissues of aggressive and non-aggressive dogs
Våge, J., Bønsdorff, T. B., Arnet, E., Tverdal, A., & Lingaas, F. (2010) · BMC Veterinary Research · doi:10.1186/1746-6148-6-34 · Cited by 35
(2022) · doi:10.1002/9781119618515.ch22 · Cited by 5
Metadata
- Authors
- SEKSEL, K., & LINDEMAN, M.
- Venue
- Australian Veterinary Journal
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 79
- Issue
- 4
- Pages
- 252-256
- ISSN
- 0005-0423 (ISSN-L)
- 1751-0813
- OpenAlex
- W2079250933
- Cited by
- 98
- References
- 0
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of clomipramine in treatment of obsessive‐compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. https://app.cochat.ai/papers/10.1111/j.1751-0813.2001.tb11976.x
- The paper
- SEKSEL, K., & LINDEMAN, M. (2001). Use of clomipramine in treatment of obsessive‐compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. Australian Veterinary Journal. https://doi.org/10.1111/j.1751-0813.2001.tb11976.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.